Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
BPC-157 is often labeled with disclaimers such as Not for human consumption or For research purposes only, and is not listed in the FDAs Approved Drugs database
For broader background on peptide biology and applications, see our overview of what a peptide is and the educational page on the Thymogen peptide
It was examined that BP collected from Attalea funifera can have leishmanicidal activity against amastigote and promastigote types of Leishmania amazonensis due to various active compounds (126)
Documented mechanisms of action Preclinical studies (mostly Russian, to be reproduced in international protocols) report several mechanistic targets: BDNF increase (Brain-Derived Neurotrophic Factor) in the hippocampus and frontal cortex, measured by ELISA and Western blot 24-72 h post-administration Monoaminergic system modulation : cortical dopamine increase, serotonergic modulation Activation of the melanocortin pathway via MC4R receptors (residue shared with ACTH) Anti-oxidant and anti-apoptotic effect in cerebral ischaemia models (MCAO, middle cerebral artery occlusion) Experimental paradigms The most reported rodent models are the Morris water maze (spatial memory), novel object recognition (recognition memory), passive avoidance (aversive learning)
explains the differences
.webp)
